来源:环球市场播报
FDA定于7月召开咨询会议,讨论目前受到限制的某些肽类药物是否可以进行复配,此举对CVS健康(CVS)等大型药房运营商具有影响。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.